Astrazeneca (AZN) EBITDA Margin (2009 - 2026)
Astrazeneca (AZN) posted EBITDA Margin of 33.11% for Q2 2026, down 0.77 percentage points from 33.87% a year earlier and down 3.60 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Astrazeneca was 33.12%, up 1.00 percentage points year-over-year; for FY2025, it was 33.16%, up 2.29 percentage points from FY2024.
- Annual EBITDA Margin has increased for four consecutive years, with a five-year change of +1.93 percentage points (FY2020 to FY2025).
- In prior years, Astrazeneca's EBITDA Margin was 30.87% in FY2024 (+1.22 pp), 29.64% in FY2023 (+8.82 pp), 20.83% in FY2022 (+0.55 pp) and 20.27% in FY2021 (-10.95 pp).
- Quarterly EBITDA Margin has run from a low of 11.29% in Q3 2021 to a high of 37.24% in Q1 2023 over five years.
- On a year-over-year basis, EBITDA Margin increased in four of the last six quarters, with an average year-over-year change of +1.45 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q1 2023, with a gain of 18.04 percentage points; the weakest was Q4 2021, with a drop of 35.99 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 36.71% (Q1 2026), 28.96% (Q4 2025) and 33.78% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 7.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.11% |
| Mar 31, 2026 | 36.71% |
| Dec 31, 2025 | 28.96% |
| Sep 30, 2025 | 33.78% |
| Jun 30, 2025 | 33.87% |
| Mar 31, 2025 | 36.49% |
| Dec 31, 2024 | 29.37% |
| Sep 30, 2024 | 28.92% |
| Jun 30, 2024 | 31.11% |
| Mar 31, 2024 | 34.47% |
| Jun 30, 2023 | 32.69% |
| Mar 31, 2023 | 37.24% |
| Jun 30, 2022 | 17.60% |
| Mar 31, 2022 | 19.20% |
| Dec 31, 2021 | 15.82% |
| Sep 30, 2021 | 11.29% |
| Jun 30, 2021 | 22.87% |
| Mar 31, 2021 | 36.78% |
| Dec 31, 2020 | 51.81% |
| Sep 30, 2020 | 29.98% |
API Access
Astrazeneca EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();